검색결과 : 18건
| No. | Article |
|---|---|
| 1 |
High level expression and characterization of the recombinant immunotoxin DAB389-4D5 scFv targeting HER2/neu-positive ovarian carcinoma cells Wang Z, Zhang J, Wang XD, Wei DZ Process Biochemistry, 80, 26, 2019 |
| 2 |
Construction and characterization of the recombinant immunotoxin RTA-4D5-KDEL targeting HER2/neu-positive cancer cells and locating the endoplasmic reticulum Jiao PY, Zhang J, Dong YG, Wei DZ, Ren YH Applied Microbiology and Biotechnology, 102(22), 9585, 2018 |
| 3 |
Production and quality control assessment of a GLP-grade immunotoxin, D2C7-(scdsFv)-PE38KDEL, for a phase I/II clinical trial Chandramohan V, Pegram CN, Piao H, Szafranski SE, Kuan CT, Pastan IH, Bigner DD Applied Microbiology and Biotechnology, 101(7), 2747, 2017 |
| 4 |
Development of a recombinant immunotoxin for the immunotherapy of autoreactive lymphocytes expressing MOG-specific BCRs Stepanov A, Belyy A, Kasheverov I, Rybinets A, Dronina M, Dyachenko I, Murashev A, Knorre V, Sakharov D, Ponomarenko N, Tsetlin V, Tonevitsky A, Deyev S, Belogurov A, Gabibov A Biotechnology Letters, 38(7), 1173, 2016 |
| 5 |
Development of a recombinant hCG-specific single chain immunotoxin cytotoxic to hCG expressing cancer cells Nand KN, Gupta JC, Panda AK, Jain SK Protein Expression and Purification, 106, 10, 2015 |
| 6 |
Development and Scale-Up of a Commercial Fed Batch Refolding Process for an Anti-CD22 Two Chain Immunotoxin Linke T, Aspelund MT, Thompson C, Xi GL, Fulton A, Wendeler M, Pabst TM, Wang XY, Wang WK, Ram K, Hunter AK Biotechnology Progress, 30(6), 1380, 2014 |
| 7 |
Purification of clinical-grade disulfide stabilized antibody fragment variable-Pseudomonas exotoxin conjugate (dsFv-PE38) expressed in Escherichia coli Jiang H, Xie YQ, Burnette A, Roach J, Giardina SL, Hecht TT, Creekmore SP, Mitra G, Zhu JW Applied Microbiology and Biotechnology, 97(2), 621, 2013 |
| 8 |
Recombinant expression and purification of a tumor-targeted toxin in Bacillus anthracis Bachran C, Abdelazim S, Fattah RJ, Liu SH, Leppla SH Biochemical and Biophysical Research Communications, 430(1), 150, 2013 |
| 9 |
Production of Anti-Cancer Immunotoxins in Algae: Ribosome Inactivating Proteins as Fusion Partners Tran M, Henry RE, Siefker D, Van C, Newkirk G, Kim J, Bui J, Mayfield SP Biotechnology and Bioengineering, 110(11), 2826, 2013 |
| 10 |
Development of a GMP Phase III purification process for VB4-845, an immunotoxin expressed in E. coli using high cell density fermentation Premsukh A, Lavoie JM, Cizeau J, Entwistle J, MacDonald GC Protein Expression and Purification, 78(1), 27, 2011 |